People: Chugai Pharmaceutical Co Ltd (4519.T)
2,434JPY
22 May 2013
¥6 (+0.25%)
¥2,422
¥2,420
¥2,437
¥2,403
397,100
1,623,305
¥2,550
¥1,379
Nagayama, Osamu
Brief Biography
Mr. Osamu Nagayama has been serving as Chairman of the Board, Chief Executive Officer and Representative Director in CHUGAI PHARMACEUTICAL CO., LTD. since March 28, 2012. He joined the Company in November 1978 and has been holding a directorship in the Company since March 1985. His previous titles include Chief Operating Officer, Deputy Chief Director of Development Planning, Managing Director, Vice President and Director. He used to work for Long-Term Credit Bank of Japan.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Osamu Nagayama |
-- |
Tatsuro Kosaka |
-- |
Motoo Ueno |
-- |
Yoshio Itaya |
-- |
Tatsumi Yamazaki |
-- |
Naotaka Nakamura |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
